CytomX Therapeutics   Report issue

For profit Phase 1 Phase 2
Founded: South San Francisco CA United States (2008)

Organization Overview

First Clinical Trial
2017
NCT03013491
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

CytomX Therapeutics | CytomX Therapeutics, Inc.